Medscape

BIOFLOW-V: Orsiro Bests Workhorse Xience at 12 Months

BARCELONA, SPAIN —The biodegradable-polymer Orsiro sirolimus-eluting stent (Biotronik) proved superior to the durable-polymer Xience everolimus-eluting stent (Abbott Vascular) for 12-month target ...
TCTMD

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

BARCELONA, Spain—Among all the big trials airing results at the European Society of Cardiology (ESC) Congress 2017, one tiny stent—and its performance—could have slipped through the cracks. Earlier ...
Healio

BIOFLOW V: Bioresorbable polymer DES reduces risk for TLR, target vessel MI

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Patients with CAD who underwent PCI with an ultrathin, bioresorbable polymer sirolimus-eluting stent ...
TCTMD

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

Final 5-year follow-up from the BIOFLOW V trial continues to show advantages for the ultrathin-strut bioresorbable-polymer Orsiro DES (Biotronik) over the thin-strut, durable-polymer Xience (Abbott), ...
Medscape

BIOFLOW II: New Bioabsorbable-Polymer/Thin-Strut Sirolimus Stent Shows Promise

PARIS, France — A new sirolimus-eluting stent boasting a biodegradable polymer and a thin-strut design that is 25% thinner than the market-leading, permanent-polymer stent has shown promising results ...
Healio

Benefits of ultrathin-strut bioresorbable polymer DES remain at 5 years: BIOFLOW-V

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. “The final 5-year follow-up data confirms Orsiro’s ...